AtriClip: One Quick Simple Step,
A Lifetime of Stroke Risk Reduction

Reduce the Risk of Stroke* - with one quick simple step
By Eliminating the LAA – recommended class I ESC/EACTS
With AtriClip Devices – proven of >98% successful exclusion

AtriClip Devices are:

  • specifically designed for LAAE
  • now indicated for use in patients at high risk of thromboembolism for whom left atrial appendage exclusion is warranted.

*Originated from the LAA

Seize the chance, exclude the LAA

AtriCures AtriClip products are the most widely sold Left Atrial Appendage (LAA) management devices worldwide.

>98%

Successful LAA exclusion1

A portfolio of proven devices to eliminate the LAA

The closed loop AtriClip devices

AtriClip® FLEX device

  • Plunger grip
  • 6cm flexible shaft
  • Available in four sizes
Open Accesses

AtriClip® PRO® device

  • Quick deploy feature
  • 25cm rigid shaft
  • ±30° omnidirectional head articulation with lock
  • Includes Selection Guide (CGG)
Minimal Accesses

AtriClip® PRO2® device

  • Hoopless end effector
  • Active articulation levers
  • Small diameter end effector (12mm)
Minimal Accesses

The open AtriClip devices

AtriClip® FLEX•V® device

  • Small footprint to minimize the interference with adjacent structures and enhance LAA visualization
  • Suture-less clip deployment
  • Reduced fatigue clip opening lever
  • One handed application
Open Accesses

AtriClip® PRO•V® device

  • 12mm port compatibility
  • Tip-first closure
  • Open-ended design clip
Minimal Accesses

Concomitant LAAE is now Class I recommendation for AF patients undergoing cardiac surgery by ESC/EACTS 2024 Guidelines

FIND OUT MORE

LAAE is safe and beneficial for the patient

num

LAAE for patients with AF: What proof?

Whitlock MD et al, 2021

Surgical LAAO reduced ischemic stroke by 42% after the perioperative period
There was no evidence of adverse effects from surgical LAA03

num

LAAE: What’s the best technique?

Petersen J et al; 2024

LAA clipping and surgical LAA excision proved to be successful LAA closure methods
The AtriClip device achieved 98,4% of success4

Additional supporting data:

  • Left atrial appendage elimination is frequently Incomplete (3 techniques of LAA elimination: internal suture ligation, external stapled excision, and surgical excision)6. Lee, R. et al, 2016
  • Successful I AA closure occurred more often with excision (73%) than suture exclusion (23%) and stapler exclusion (0%) (p 0.001)7 Kanderian et al, 2008

num

AtriClip for LAAE: Safety & Efficacy

Toale et al, 2019

The AtriClip device achieved complete LAA closure in 97.8%5

“In 2024, we must have a valid reason for not performing concomitant AF surgery in patients with a history of AF who are undergoing CABG, MVR, AV, or a combination of it.

Otherwise, we are not providing an acceptable standard of care to our patients”

James L. Cox, MD
PM-EU-3912A-0127-G

References

Clinical results are not predictive and individual results may vary.

  1. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61(2):755-759.
  2. Glikson M, Wolff R, Hindricks G, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update. EuroIntervention. 2020;15(13):1133-1180.
  3. Hanke T. Surgical management of the left atrial appendage: a must or a myth? Eur J Cardiothorac Surg. 2018;53(suppl_1):i33-i38.
  4. Johnson WD, Ganjoo AK, Stone CD, Srivyas RC, Howard M. The left atrial appendage: our most lethal human agachment! Surgical implications. Eur J Cardiothorac Surg. 2020;17(6):718-722.
  5. van Laar C, Verberkmoes NJ, Es HW, et al. Thoracoscopic left atrial appendage clipping. JACC: Clinical Electrophysiology. 2018;4(7):893-901.
  6. Badhwar V, Rankin JS, Damiano RJ, Jr., et al. The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. Ann Thorac . 2017;103(1):329-341.
  7. Hindricks G, Potpara T, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. ;42:373-498.
  8. Writing Group M, January CT, Wann LS, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial llation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. ;16(8):e66-e93.
  9. Ali AN, Abdelhafiz A. Clinical and Economic Implications of AF Related Stroke. J Atr Fibrillation. 2016;8(5):1279. Authors pooled data from 15 studies.
  10. Health Policy Partnership. White Paper on inequalities and unmet needs in the detection of atrial fibrillation (AF) and use of therapies to prevent AF related stroke in Europe. 2018
  11. Cullen MW, Stulak JM, Li Z, et al. Left Atrial Appendage Patency at Cardioversion After Surgical Left Atrial Appendage Intervention. Ann Thorac Surg. 2016;101(2):675-681.
  12. Soltesz EG, Dewan KC, Anderson LH, Ferguson MA, Gillinov AM. Improved outcomes in CABG patients with atrial fibrillation associated with surgical left atrial appendage usion. J Card Surg. 2021;36(4):1201-1208.
  13. Whitlock RP, Belley-Cote EP, Paparella D, et al. Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. N Engl J Med. 2021;384(22): 2081-2091.
  14. Wolf PA, Abbog RD, Kannel WB. Atrial fibrillation is an independent risk factor for stroke: The Framingham Study. Stroke. 1991;22:983-8.

Interested in learning more?

Contact us for more information and a rep will be in touch with you.

    cf7captchaRegenerate Captcha